Literature DB >> 2474615

A novel and simple procedure for determining T cell epitopes in protein antigens.

S Demotz1, P Matricardi, A Lanzavecchia, G Corradin.   

Abstract

A human T cell epitope was mapped on tetanus toxin by the use of a simple method. Tetanus toxin peptide preparations were produced by various specific chemical and proteolytic cleavages. T cell proliferative response to these peptide preparations was assayed to determine which amino acid residues were present or absent in the T cell epitope. Cyanogen bromide-derived tetanus toxin peptides were separated by electrophoresis and transferred onto nitrocellulose. T cell proliferative response to nitrocellulose fragments was assayed to determine the molecular weight of the antigenic tetanus toxin peptide. The combination of the two procedures allowed us to define a 21-mer tetanus toxin peptide recognized by the T cell clone. This method represents an easily performed alternative for the mapping of T cell epitopes on protein antigen.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2474615     DOI: 10.1016/0022-1759(89)90335-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Parasite-specific T-cell responses of trypanotolerant and trypanosusceptible cattle during infection with Trypanosoma congolense.

Authors:  J N Flynn; M Sileghem; D J Williams
Journal:  Immunology       Date:  1992-04       Impact factor: 7.397

2.  A B cell-, T cell-linked epitope located on the adhesin of Mycoplasma pneumoniae.

Authors:  E Jacobs; R Röck; L Dalehite
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

3.  An analogue peptide from the Cancer/Testis antigen PASD1 induces CD8+ T cell responses against naturally processed peptide.

Authors:  Nicola Hardwick; Sarah Buchan; Wendy Ingram; Ghazala Khan; Gisella Vittes; Jason Rice; Karen Pulford; Ghulam Mufti; Freda Stevenson; Barbara-ann Guinn
Journal:  Cancer Immun       Date:  2013-07-15

4.  Broadly protective protein-based pneumococcal vaccine composed of pneumolysin toxoid-CbpA peptide recombinant fusion protein.

Authors:  Beth Mann; Justin Thornton; Richard Heath; Kristin R Wade; Rodney K Tweten; Geli Gao; Karim El Kasmi; John B Jordan; Diana M Mitrea; Richard Kriwacki; Jeff Maisonneuve; Mark Alderson; Elaine I Tuomanen
Journal:  J Infect Dis       Date:  2013-09-16       Impact factor: 5.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.